Professor, Cardiology, Baylor College of Medicine
Cardiology
Dr. Glenn N. Levine, MD
|
|
Give Review
Glenn N. Levine, MD works in the field of Cardiology. He attended Boston University School of Medicine. Boston University School of Medicine has a rank of 30 in research and a 52 in primary care He over the years received 1 awards: "Fellow (FACC)". Glenn Levine is also published. He has 43 publications published. The lastest publication: "Accuracy and clinical utility of the mini-dose 14C-urea breath test in the evaluation of Helicobacter pylori infection.'
Publications
- Transcatheter Aortic valve replacement as a treatment for late apicoAortic conduit obstruction in a patient with severe Aortic stenosis.
- Establishment of a transcatheter Aortic valve program and heart valve team at a Veterans Affairs facility.
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention A Report of the American College of Cardiology Foundation/American Heart Association Task Force on ...
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Associa...
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Associ...
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on...
- Newer pharmacotherapy in patients undergoing percutaneous Coronary interventions: a guide for pharmacists and other health care professionals.
- Utilization of catheterization and revascularization procedures in patients with non-ST segment elevation Acute coronary syndrome over the last decade.
- Low-molecular-weight heparin during percutaneous Coronary interventions: rationale, results, and recommendations.
- Evaluation of a novel point-of-care enoxaparin monitor with central laboratory anti-Xa levels.
- Weighing the benefits and risks of magnetic resonance scanning of patients with implanted cardiovascular devices.
- Obesity in patients with non-ST-segment elevation Acute coronary syndromes: results from the SYNERGY trial.
- Relationship between renal function and outcomes in high-risk patients with non-ST-segment elevation Acute coronary syndromes: results from SYNERGY.
- Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American ...
- Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: a subgroup analysis from the SYNERGY trial.
- Arteriotomy closure devices for cardiovascular procedures: a scientific statement from the American Heart Association.
- Malignant pleural/pericardial effusion with tamponade and life-threatening reversible myocardial depression in a case of an initial presentation of lung adenocarcinoma.
- Degree of anticoagulation after one subcutaneous and one subsequent intravenous booster dose of enoxaparin: implications for patients with Acute coronary syndromes und...
- The role of endomyocardial biopsy in the management of cardiovascular Disease: a scientific statement from the American Heart Association, the American College of Card...
- Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and I...
- Pharmacoinvasive management of Acute coronary syndrome: incorporating the 2007 ACC/AHA guidelines: the CATH (cardiac catheterization and antithrombotic therapy in the ...
- Management of patients undergoing percutaneous Coronary revascularization.
- Pharmacoinvasive management of Acute coronary syndrome in the setting of percutaneous coronary intervention: evidence-based, site- and spectrum-of-care strategies for ...
- A novel point-of-care enoxaparin monitor for use during percutaneous Coronary intervention. Results of the Evaluating Enoxaparin Clotting Times (ELECT) Study.
- Universal definition of myocardial infarction.
- Relationship between heparin anticoagulation and clinical outcomes in Coronary stent intervention: observations from the ESPRIT trial.
- Strategies for optimizing outcomes in the NSTE-ACS patient The CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report.
- Reduction of thrombus burden with eptifibatide in a patient with a non-ST segment elevation Acute coronary syndrome.
- The role of low-molecular-weight heparins in non-ST-segment elevation Acute coronary syndromes.
- In-hospital costs of Coronary stent implantation with and without eptifibatide (the ESPRIT Trial). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin.
- Antithrombotic therapy in patients with Acute coronary syndromes.
- The role of percutaneous revascularization in the treatment of ischemic heart Disease: insights from published reports and randomized clinical trials.
- Impact of diabetes mellitus on percutaneous revascularization (CAVEAT-I). CAVEAT-I Investigators. Coronary Angioplasty Versus Excisional Atherectomy Trial.
- Use of bare-mounted Palmaz-Schatz stents employing the stent saddle technique on the delivery balloon: a single center experience.
- Ascorbic acid reverses endothelial vasomotor dysfunction in patients with Coronary artery disease.
- Cholesterol reduction in cardiovascular Disease. Clinical benefits and possible mechanisms.
- The benefits and risks of exercise training: the exercise prescription.
- Exercise training and blood viscosity in patients with ischemic heart Disease.
- Analytical methods and database design: implications for transplant researchers, 2005.
- SRTR program-specific reports on outcomes: a guide for the new reader.
- An analysis of risk factors for withdrawal from dialysis before death.
- Accuracy and clinical utility of the mini-dose 14C-urea breath test in the evaluation of Helicobacter pylori infection.
Schools
Columbia University College Of Physicians and Surgeons
Boston Med Center
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
Awards
- Fellow (FACC)
Education
-
Boston University School of Medicine -
Boston University Medical Center -
Columbia University College of Physicians & Surgeons
Hospital
-
Michael E. DeBakey Veterans Affairs Medical Center
Drug Facts
| NPI NUMBER | 1801814769 | |
| NPPES Provider LastName | LEVINE | |
| NPPES Provider FirstName | GLENN | |
| NPPES Provider ZIPCode | 97444 | |
| NPPES Provider State | OR | |
| Specialty Description | General Surgery | |
| Total Claim Count | 58.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1801814769 |
| Last Name Of The Provider | LEVINE |
| First Name Of The Provider | GLENN |
| View All |
Similar Doctors
|
|
Dr. Albert E. Raizner, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Jianwei Feng, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Chaitanya B. Shah, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Edward K. Massin, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mohammed S. Khan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John J. Mahmarian, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Charles E. Mullins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Angelo Nascimbene, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Achal Sahai, MD |
|
|
Dr. Lily Zhang, MD |
|
|
Dr. Saverio La Francesca, MD |
|
|
Dr. Benjamin G. Metz, DO |
|
|
Santhisri Kodali |
|
|
Dr. Tehmeena Shah, MD
This Doctor is OpenDoctor Recommended.
|